Document Preview Unavailable

Do patient characteristics affect EGFR tyrosine kinase inhibitor treatment outcomes? A network meta-analysis of real-world survival outcomes of East Asian patients with advanced non-small cell lung cancer treated with first-line EGFR-TKIs

Huang-Chih, Chang; Chin-Chou, Wang; Chia-Cheng, Tseng; Kuo-Tung, Huang; Yu-Mu, Chen; et al.  Thoracic Cancer Vol. 14, Iss. 32,  (Nov 2023): 3208-3216.

You might have access to this document